Treatment with the C5a receptor antagonist ADC-1004 reduces myocardial infarction in a porcine ischemia-reperfusion model

BACKGROUND: Polymorphonuclear neutrophils, stimulated by the activated complement factor C5a, have been implicated in cardiac ischemia/reperfusion injury. ADC-1004 is a competitive C5a receptor antagonist that has been shown to inhibit complement related neutrophil activation. ADC-1004 shields the n...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Pals, Jesper, Koul, Sasha, Andersson, Patrik, Götberg, Matthias, Ubachs, Joey FA, Kanski, Mikael, Arheden, Håkan, Olivecrona, Göran K, Larsson, Bengt, Erlinge, David
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2955599/
https://www.ncbi.nlm.nih.gov/pubmed/20875134
http://dx.doi.org/10.1186/1471-2261-10-45

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2955599/
https://www.ncbi.nlm.nih.gov/pubmed/20875134
http://dx.doi.org/10.1186/1471-2261-10-45

Ejemplares similares